Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
US Department of Justice
Boehringer Ingelheim
Merck
Express Scripts

Generated: May 20, 2019

DrugPatentWatch Database Preview

Dextromethorphan polistirex - Generic Drug Details

« Back to Dashboard

What are the generic sources for dextromethorphan polistirex and what is the scope of dextromethorphan polistirex patent protection?

Dextromethorphan polistirex is the generic ingredient in two branded drugs marketed by Rb Hlth, Amneal Pharms Llc, and Tris Pharma Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for dextromethorphan polistirex. Thirty-four suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for dextromethorphan polistirex
Synonyms for dextromethorphan polistirex
(9?,13?,14?)-3-Methoxy-17-methylmorphinan hydrobromide
(9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan HBr
(9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan hydrobromide
125-69-9
125-71-3 (Parent)
18651-95-1
6700-34-1
9-alpha,13-alpha,14-alpha-Morphinan, 3-methoxy-17-methyl-, hydrobromide
9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl-, hydrobromide (8CI)
AB2000339
AKOS022186323
Allfen-DM
AN-22966
Antussan
API0002284
BCP06595
Benylin DM
Canfodion
CCG-212567
Cosylan
CS-2858
d-3-Methoxy-N-methylmorphinan hydrobromide
d-Methorphan hydrobromide
Delsym
Demorphan
Demorphan hydrobromide
Demorphine
Dextromethorphan (hydrobromide)
Dextromethorphan bromide
Dextromethorphan HBr
Dextromethorphan hydrobromide
Dextromethorphan Hydrobromide (anhydrous)
Dextromethorphan hydrobromide anhydrous
Dextrometorphan hydrobromide
Dextroramin P
Dormetan
Dormethan
DTXSID60872346
DXM HBr
EINECS 204-750-1
Hihustan M.
HY-B0620
LS-91843
Medicon
Methorate hydrobromide
Metrorat
MISZALMBODQYFT-URVXVIKDSA-N
morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-, hydrobromide
Morphinan, 3-methoxy-N-methyl-, hydrobromide, (+)-
Ro 1-5470/5
Romilar
Romilar hydrobromide
SCHEMBL121924
Tusilan
Tussade
UNII-131YWR720Z component MISZALMBODQYFT-URVXVIKDSA-N
UNII-Z0CG3115FG
Z0CG3115FG

US Patents and Regulatory Information for dextromethorphan polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Llc DEXTROMETHORPHAN POLISTIREX dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 203133-001 Jul 28, 2017 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tris Pharma Inc DEXTROMETHORPHAN POLISTIREX dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 091135-001 May 25, 2012 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rb Hlth DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 OTC Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for dextromethorphan polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rb Hlth DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ➤ Sign Up ➤ Sign Up
Rb Hlth DELSYM dextromethorphan polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018658-001 Oct 8, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Accenture
Federal Trade Commission
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.